Oarsman Capital, Inc. Zoetis Inc. Transaction History
Oarsman Capital, Inc.
- $706 Million
- Q3 2025
A detailed history of Oarsman Capital, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 1,999 shares of ZTS stock, worth $237,481. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,999
Previous 2,071
3.48%
Holding current value
$237,481
Previous $322,000
9.32%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding ZTS
# of Institutions
2,074Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...